Partner International has been mandated by a Multi-National Big Pharma to manage the divestment of a North American based manufacturing facility, along with a marketed cardiovascular asset. Within the first weeks of engagement, Partner International contacted more than 3,000 potential buyers and is currently in negotiations.
Partner International is representing a leading Middle Eastern pharmaceutical distributor. Partner International is securing agreements with international companies seeking product commercialization and representation in the Middle East – we have direct presence in the growing markets of Lebanon, Jordan, Syria, Palestine, and Iraq, as well as strategic alliances in Saudi Arabia, the United Arab Emirates, and Kuwait.
An unparalleled Contract Manufacturer has engaged Partner International to identify and secure new customers for their parenteral manufacturing capabilities, utilizing their tailored controlled release drug delivery technology.
